Akari Therapeutics (AKTX) P/E (2015 - 2026)
Akari Therapeutics (AKTX) P/E from Sep 30, 2015 to Jul 20, 2026. The TTM Akari Therapeutics (AKTX) P/E is -1.09K. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Akari Therapeutics (AKTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.09K | -7.79% |
| 2025 | -1.18K | -82.89% |
| 2024 | -6.88K | +56.50% |
| 2023 | -4.40K | +197.11% |
| 2022 | -1.48K | -68.67% |
| 2021 | -4.73K | -18.92% |
| 2020 | -5.83K | +5.71% |
| 2019 | -5.51K | +11.46% |
| 2018 | -4.95K | -63.74% |
| 2017 | -13.64K | -38.49% |
| 2016 | -22.18K | -210.26% |
| 2015 | 20.12K | N/A |
Comparison Akari Therapeutics (AKTX) P/E with competitors
Akari Therapeutics (AKTX) P/E is -1086.48.